Abstract: The present invention relates, in general, to oncoimmunins. In particular, the present invention relates to oncoimmunin-lymphoid factor and oncoimmunin-myeloid factor, pharmaceutical compositions of said factors, and methods of use of said factors.
Type:
Grant
Filed:
September 23, 1991
Date of Patent:
November 15, 1994
Assignee:
The United States of America as represented by the Secretary of the Department of Health and Human Services